Skip to Content
Merck
CN
All Photos(1)

Key Documents

Safety Information

SRP4178

Sigma-Aldrich

IL-17A from rat

recombinant, expressed in E. coli, ≥95% (SDS-PAGE), ≥95% (HPLC)

Synonym(s):

Ctla8, IL17, IL17a

Sign Into View Organizational & Contract Pricing


About This Item

MDL number:
UNSPSC Code:
12352202
NACRES:
NA.32

biological source

rat

recombinant

expressed in E. coli

Assay

≥95% (HPLC)
≥95% (SDS-PAGE)

form

lyophilized

potency

30 ng/mL

mol wt

~30 kDa

packaging

pkg of 10 μg

storage condition

avoid repeated freeze/thaw cycles

impurities

endotoxin, tested

NCBI accession no.

UniProt accession no.

shipped in

wet ice

storage temp.

−20°C

Gene Information

General description

IL-17A (interleukin 17A) is the first cytokine member of the family composed of IL-17A-F. These cytokines are mainly produced by activated CD4+ (cluster of differentiation) T cells. IL-17A is predominantly synthesized by T-helper (Th)-17 lymphocytes, γδ T cells (γδ-17), cytotoxic CD8+ T cells (Tc17), natural killer T (NKT) cells, and neutrophils.

Biochem/physiol Actions

IL-17A (interleukin 17A) acts as a regulator of immune responses in inflammatory disorders, and acts as a potent pleiotropic proinflammatory cytokine where it promotes the release of other pro-inflammatory cytokines from a variety of cells. This cytokine is linked with pain, and IL-17A and IL-17A+ T cells are found in patients with arthritic pain, and in induced animal models of sciatic nerve, and optic nerve injury with neuropathic pain. This protein is thought to be involved in myocardial remodeling and fibrosis, where it promotes the synthesis of collagens and matrix metalloproteinases (MMPs) and activates cardiomyocyte apoptosis.
Recombinant rat IL-17 produced from Escherichia coli is a homodimeric, non-glycosylated polypeptide containing 268 amino acids and has a molecular weight of 30kDa.

Physical form

Lyophilized (from 10 mM Sodium Citrate, pH 3.0).

Reconstitution

Centrifuge the vial prior to opening. Avoid freeze-thaw cycles.
Reconstitute in water to a concentration of 0.1-1.0 μg/μL (Note: Gently pipetting to dissolve). The solution can then be diluted into other aqueous buffers.

Regulatory Information

新产品

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Wendy Dankers et al.
Arthritis research & therapy, 20(1), 212-212 (2018-09-22)
Despite recent improvements in the treatment of rheumatoid arthritis (RA), an insufficient treatment response and the development of treatment resistance in many patients illustrates the need for new therapeutic strategies. Chronic synovial inflammation could be suppressed by targeting RA synovial
Interleukin-17A Exacerbates Ferric Chloride-Induced Arterial Thrombosis in Rat Carotid Artery.
Maione F et al
International Journal of Inflammation, 2014, 247503-247503 (2014)
Baraa Noueihed et al.
Frontiers in cell and developmental biology, 9, 630645-630645 (2021-02-09)
Ischemic retinopathies (IRs), such as retinopathy of prematurity and diabetic retinopathy, are characterized by an initial phase of microvascular degeneration that results in retinal ischemia, followed by exaggerated pathologic neovascularization (NV). Mesenchymal stromal cells (MSCs) have potent pro-angiogenic and anti-inflammatory
Lisa Wolf et al.
American journal of physiology. Lung cellular and molecular physiology, 311(5), L1015-L1022 (2016-10-04)
Lung epithelial cells are suggested to promote pathogen-induced pulmonary inflammation by the release of chemokines, resulting in enhanced recruitment of circulating leukocytes. Recent studies have shown that the interleukin-17C (IL-17C) regulates innate immune functions of epithelial cells in an autocrine
Ting Li et al.
Frontiers in immunology, 9, 1118-1118 (2018-06-12)
Pneumocystis pneumonia (PCP) remains a severe complication with high mortality in immunocompromised patients. It has been well accepted that CD4+ T cells play a major role in controlling Pneumocystis infection. Th9 cells were the main source of IL-9 with multifaced

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service